Edition:
India

Shanghai Pharmaceuticals Holding Co Ltd (601607.SS)

601607.SS on Shanghai Stock Exchange

25.70CNY
17 Jan 2018
Change (% chg)

-- (--)
Prev Close
¥25.70
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
13,591,244
52-wk High
¥29.25
52-wk Low
¥20.40

Chart for

About

Shanghai Pharmaceuticals Holding Co., Ltd. is a China-based company principally engaged in the manufacture and sales of pharmaceuticals. The Company's businesses include the research and registration, production, sales, distribution and retailing of pharmaceutical products, among others. Its products are applied in cardiovascula... (more)

Overall

Beta: 0.95
Market Cap(Mil.): ¥58,598.07
Shares Outstanding(Mil.): 2,688.91
Dividend: 0.36
Yield (%): 1.52

Financials

  Industry Sector
P/E (TTM): -- 21.41 16.44
EPS (TTM): -- -- --
ROI: -- 11.89 10.61
ROE: -- 13.52 14.21

BRIEF-Shanghai Pharmaceuticals Holding units receive GMP certificate

* Says Changzhou-based pharmaceuticals unit received goods manufacture practice (GMP) certificate from Jiangsu Food and Drug Administration, for its products including acyclovir, ganciclovir and production line

10 Jan 2018

BRIEF-Shanghai Pharmaceuticals Holding unit receives GMP certificate

* Says its unit received goods manufacture practice (GMP) certificate from Shandong Food and Drug Administration, for its products including mixture, oral liquid, drops and bulk drug

05 Jan 2018

BRIEF-Shanghai Pharmaceuticals Holding Announces ‍CSRC's Approval On Issuance Of New Shares

* ANNOUNCES ‍CSRC'S APPROVAL ON ISSUANCE OF NEW 153.2 MILLION H SHARES AT VALUE OF RMB1 PER SHARE​ Source text for Eikon: Further company coverage:

29 Dec 2017

BRIEF-Shanghai Pharmaceuticals Gets Regulatory Approval To Issue Up To 153.2 Mln H-Shares

* SAYS IT GETS SECURITIES REGULATOR'S APPROVAL TO ISSUE UP TO 153.2 MILLION H-SHARES Source text in Chinese: http://bit.ly/2C81gx7 Further company coverage: (Reporting by Hong Kong newsroom)

29 Dec 2017

BRIEF-Shanghai Pharmaceuticals Holding To Transfer Entire Stake In Shanghai Huashi Asset Management

* ANNOUNCES ‍TRANSFER OF 100% EQUITY INTEREST IN SHANGHAI HUASHI ASSET MANAGEMENT CO TO A CONTROLLING SHAREHOLDER​

19 Dec 2017

BRIEF-Shanghai Pharmaceuticals Holding unit receives GMP certificate

* Says its wholly owned unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration

11 Dec 2017

BRIEF-Shanghai Pharmaceuticals Holding unit receives GMP certificate

* Says its Shanghai-based unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration

05 Dec 2017

BRIEF-Shanghai Pharmaceuticals Holding unit receives GMP certificate

* Says its wholly owned unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration

03 Dec 2017

BRIEF-Shanghai Pharmaceuticals Holding unit to take out loan of $100 mln

* Says co's Hong Kong-based wholly owned unit will take out loan of $100 million (about 664 million yuan) form co's controlling shareholder, with term of 180 days

16 Nov 2017

Shanghai Pharma buys U.S. Cardinal Health's China business for $557 million

Shanghai Pharmaceuticals Holding Co has agreed to buy Cardinal Health Inc's China drug distribution business for $557 million, winning a highly competitive auction in a move that will greatly expand its presence nationwide.

15 Nov 2017

Earnings vs. Estimates